03:35 AM EDT, 10/17/2025 (MT Newswires) -- Praxis Precision Medicines ( PRAX ) said late Thursday it priced an underwritten public offering of about 3 million shares at $157 apiece and pre-funded warrants to purchase up to 318,470 shares at $156.9999 per warrant.

The company expects to raise gross proceeds of about $525 million from the offering, which is expected to close on or about Oct. 20.

Praxis said it granted underwriters a 30-day option to purchase up to an additional 501,592 shares.